Program

107
769
585
109
103
36
26
22
16
11
10
10
9
4
3
1

Journal Year Published

4
11
15
29
12
8
10
9
6
2
1

Author

89
73
30
26
24
19
16
14
10
8
8
8
8
7
7
7
7
6
6
6

Category

57
51
30
19
8
4
3
2
1

Keyword

44
23
15
13
12
12
11
9
9
8
8
7
7
7
6
6
5
5
5
5

Journal

12
7
7
5
4
4
4
3
3
3
3
3
2
2
2
1
1
1
1
1

NCATS Publications

Toxicogenomics: A 2020 Vision.


Liu Z, Huang R, Roberts R, Tong W


Trends Pharmacol. Sci. , (40), 92-103, 2019.

Article Pubmed

Sample image from publication page

Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic Studies.


Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu P, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin C, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A


Environ. Health Perspect. , (126), 077010, 2018.

Article Pubmed

Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.


Wen Z, Liang Y, Hao Y, Delavan B, Huang R, Mikailov M, Tong W, Li M, Liu Z


Drug Discov. Today , (24), 9-15, 2019.

Article Pubmed

Sample image from publication page

Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.


Yang S, et al.


Cell Discov , (4), 31, 2018.

Article Pubmed

Sample image from publication page

Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis.


Zhang X, Yang L, Liu Y, Song Z, Zhao J, Chen D, Yu H, Li R, Wang Y, Yang K, Chen Y, Xia M, Zhang LW


Toxicol. Appl. Pharmacol. , (348), 54-66, 2018.

Article Pubmed

Sample image from publication page

The US Federal Tox21 Program: A strategic and operational plan for continued leadership.


Thomas RS, Paules RS, Simeonov A, Fitzpatrick SC, Crofton KM, Casey WM, Mendrick DL


ALTEX , (35), 163-168, 2018.

Article Pubmed